103.06USD+2.29%Mkt Cap: 179.58B $P/E: 33.373d ago
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nu…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap179.58B $
Enterprise Value206.99B $
Revenue (TTM)46.58B $
Gross Profit25.01B $
Net Income (TTM)6.52B $
Revenue/Share26.79 USD
Last Price103.06 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees122.0K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS0028241000
Valuation
P/E (Trailing)33.37
P/E (Forward)16.99
PEG2.08
EV/EBITDA17.44
EV/Revenue4.44
P/S3.85
P/B3.45
EPS (TTM)3.09
EPS (Forward)6.06
52W Range
81.9738% of range137.49
52W High137.49 USD
52W Low81.97 USD
Profitability
Gross Margin56.42%
Oper. Margin14.15%
EBITDA Margin25.47%
Profit Margin14.72%
ROE12.51%
ROA7.52%
Growth
Revenue Growth13.00%
Earnings Growth-47.50%
Cash Flow & Leverage
Operating CF9.57B $
CapEx (TTM)2.17B $
FCF Margin—
FCF Yield—
Net Debt26.84B $
Net Debt/EBITDA2.26
Balance Sheet
Debt/Equity0.27
Current Ratio—
Quick Ratio—
Book Value/Sh29.89 USD
Cash/Share4.188 USD
Dividends
Fwd Div Rate2.520 USD
Trail. Div Rate2.480 USD
Div. Yield2.45%
5Y Avg Yield1.82%
Payout Ratio78.96%
Ex-Div DateJul 15, 2026
Pay DateAug 17, 2026
Splits
Last Split10000:4798
Split DateJan 2, 2013
Analyst Consensus
Rating1.7 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)119.13 USD
Upside (mean)+15.6%
Target Range103.00 USD – 135.00 USD
$103.00+15.6% to mean$135.00
# Analysts24
Ownership
Shares Out.1.74B
Float1.73B
Insiders0.49%
Institutions82.52%
Short Interest
Short Ratio1.8d
Short % Float1.59%
Short % Out.1.43%
Shares Short24.85M
Short (prev mo.)21.97M
Technical
SMA 5091.28 (+12.9%)
SMA 200109.02 (-5.5%)
Beta0.61
S&P 52W Chg16.00%
Avg Vol (30d)10.35M
Avg Vol (10d)14.99M
Technical Indicators
RSI (14)68.1
MACD2.8616
MACD Signal1.9548
MACD Hist.+0.9068
BB Upper103.85 USD
BB Middle94.78 USD
BB Lower85.72 USD
BB Width19.13%
ATR (14)3.029 USD
Vol Ratio (20d)0.85x